Kosei Matsue1, Meletios Dimopoulos2, Katja Weisel3, Philippe Moreau4, Larry D.Anderson Jr5, Darrell White6, Jesus Miguel San7, Pieter Sonneveld8, Monika Engelhardt9, Matthew Jenner10, Jan Durig11, Michel Pavic12, Morten Salomo13, Xin Yu14, Tuong Nguyen Vi14, Tsvetan Biyukov15, Teresa Peluso15, Paul Richardson16
1Kameda Medical Center, 2National and Kapodistrian University of Athens, 3University Hospital of Tuebingen, 4University Hospital Hotel-Dieu, 5University of Texas Southwestern Medical Center, 6Dalhousie University and Queen Elizabeth II Health Sciences Centre, 7Clinica Universidad de Navarra, CIMA, IDISNA, 8Erasmus MC Cancer Institute, 9Universitatsklinikum Freiburg, 10Southampton General Hospital, 11University Hospital Essen, 12Centre Hospitalier Universitaire De Sherbrooke (CHUS) - Centre de Recherche Clinique Etienne-Le Bel (CRCELB) Hopital Fleurimont, 13Copenhagen University Hospital, Rigshospitalet, 14Celgene Corporation, 15Celgene International, 16Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School
International Journal of Myeloma 9(1): 164-164, 2019.